Blackstone is expected to launch a sale process review of portfolio company Precision Medicine Group’s contract research organization and pharmaceutical commercialization groups in the coming months, three sources familiar with the matter told PE Hub senior reporter Michael Schoeck. Blackstone acquired Precision Medicine Grouop from Berkshire Partners and TPG Growth for between $2.3bn and $2.4bn in late 2020.
Read the full article: Blackstone to Test Buyout Market for PMG’s CRO and Pharma Commercialization Divisions, Sources Say //
Source: https://www.pehub.com/exclusive-blackstone-to-test-buyout-market-for-pmgs-cro-and-pharma-commercialization-divisions-sources-say/